Page 147 - Withrow and MacEwen's Small Animal Clinical Oncology, 6th Edition
P. 147

7


  VetBooks.ir


         Diagnostic Cytopathology in Clinical



         Oncology




         KRISTEN R. FRIEDRICHS AND KAREN M. YOUNG








         In veterinary oncology, cytologic evaluation plays several impor-  features of the tumor described. Staging procedures often include
         tant roles that aid in clinical decision making, including making a   cytologic evaluation of regional lymph nodes (LNs). Importantly,
         preliminary or definitive diagnosis, planning diagnostic and treat-  LNs containing metastatic disease are not always enlarged, and
         ment strategies, determining prognosis through staging, detecting   thus normal-sized LNs should be sampled. For detection of solid
         recurrence, and monitoring response to therapy. An understand-  tumor metastasis to regional LNs, fine-needle aspiration (FNA) is
                                                                                     1
         ing of the advantages and limitations of cytologic evaluation is   highly sensitive and specific ; however, metastatic disease may be
         necessary to use this diagnostic modality effectively in clinical   present even if tumor cells are not identified in a sample collected
         oncology.                                             from an LN; in this case, histologic evaluation may be required.
            Advantages of cytologic evaluation include the ability to evalu-
         ate the morphologic appearance of individual cells, the relatively   Sample Collection
         low risk of procedures to the patient, the lower cost compared
         with surgical biopsy, and the speed with which results can be   Proper collection and preparation techniques are prerequisites to
         obtained. Cytologic evaluation also has several limitations. The   obtaining diagnostic samples of high quality. Supplies necessary for
         amount of tissue sampled is small compared with that obtained   collecting cytologic samples from a variety of tissues, body cavities,
         from a surgical biopsy; therefore cytologic specimens may not   and mucosal surfaces are available in most clinics. These include
         be fully representative of the lesion. Sample quality may be poor   hypodermic needles and syringes, scalpel blades and handles, pro-
         because of factors intrinsic to the lesion or poor collection tech-  pylene urinary catheters, bone marrow aspiration needles, cotton
         nique. Importantly, the inability to evaluate architectural relation-  swabs, clean glass slides, marking pencils, and collection vials and
         ships among cells in cytologic specimens may prevent distinction   tubes (tubes with ethylenediaminetetraacetic acid [EDTA] and
         between reactive and neoplastic processes or between benign and   plain sterile tubes). For aspiration of internal lesions, obtained
         malignant tumors. Examination of histologic samples, in which   by guidance with ultrasonography or computed tomography
         tissue architecture is preserved, may be required to make a defini-  (CT), longer spinal needles and extension sets (used to connect
         tive diagnosis of neoplasia, determine tumor type, and assess the   the spinal needle to the aspirating syringe) are useful. Cytologic
         extent of the lesion, including metastasis. Even then, ancillary   specimens also can be made from tissues collected during surgical
         tests such as immunohistochemical staining or tests for clonality   biopsy (see Chapter 9). All supplies should be assembled in one
         may be required. Often, cytologic evaluation precedes a surgical   location for ready access. Although life-threatening situations are
         biopsy and provides information that assists in formulating subse-  rarely encountered when collecting cytologic specimens, supplies
         quent diagnostic and treatment procedures.            and medications should be available to control bleeding and to
            Some tumors, such as lymphoma, may often be definitively   treat anaphylaxis. The latter can occur rarely when aspirating mast
         diagnosed and staged using cytologic evaluation exclusively, and   cell tumors (MCTs) because of release of histamine.
         treatment can be initiated without the need to collect histologic   For external or easily accessible lesions, such as cutaneous and
         specimens. For other tumors, such as well-differentiated hepato-  subcutaneous masses or enlarged LNs, aspiration simply requires
         cellular carcinoma, cytologic examination permits formulation of   stabilization of the mass and consideration of underlying struc-
         a list of differential diagnoses, and histologic evaluation must be   tures, such as large vessels and nerves. Some large abdominal
         performed for definitive diagnosis. At a minimum, categorization   masses can be aspirated blindly if they can be stabilized and if they
         of a tumor as an epithelial, mesenchymal, or discrete round cell   are unlikely to be highly vascular or an abscess, aspiration of which
         tumor often can be determined cytologically; this may be sufficient   may result in hemorrhage or dissemination of infection, respec-
         for initial discussions with the owner about diagnosis and prog-  tively. Aspiration of intrathoracic and intraabdominal lesions is
         nosis. Staging the malignancy, monitoring therapy, and detecting   typically accomplished with guidance by imaging, either by ultra-
         recurrence using cytologic evaluation are more easily accomplished   sonography or by CT, to aid in targeting the lesion and avoiding
         once a definitive diagnosis has been made and cytomorphologic   large vessels and other sensitive areas. Defects in cortical bone also


         126
   142   143   144   145   146   147   148   149   150   151   152